Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07648095 · ClinicalTrials.gov registry record
Lacrifill for Ocular Surface Optimization in Cataract Surgery
A clinical trial, sponsored by The Eye Institute of West Florida.
- Not yet
- Registry status
- 65
- Enrollment target
NCT07648095: Clinical Trial study, sponsored by The Eye Institute of West Florida.
NCT07648095 is a clinical trial that has not yet begun recruiting, run by The Eye Institute of West Florida. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07648095 has not yet begun recruiting, sponsored by The Eye Institute of West Florida.
- NOT YET RECRUITING
- Registry status
- 65 participants
- Enrollment target
Study Summary
This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
Primary Outcome
Difference in mean spherical equivalent Mean Absolute Error (MAE) between actual postoperative manifest refraction spherical equivalent and back-calculated equivalent based on baseline biometry.
Interventions
- DEVICE Lacrifill Canalicular Filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-07-15 |
What is known before NCT07648095 opens enrollment
NCT07648095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lacrifill Canalicular Filler is the first listed.
NCT07648095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07648095 about?
NCT07648095 is a clinical study titled "Lacrifill for Ocular Surface Optimization in Cataract Surgery". This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
What is the current status of trial NCT07648095?
This trial is currently not yet recruiting. The enrollment target is 65 participants. The study started on 2026-07-15. Estimated completion is 2027-07-15.
What interventions are being tested in trial NCT07648095?
The interventions under investigation include: Lacrifill Canalicular Filler (DEVICE).
Who is sponsoring clinical trial NCT07648095?
This trial is sponsored by The Eye Institute of West Florida, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI